Podcast


Presenter: James McCormack Pharm D Mike Kolber MD MSc CCFP Tony Nickonchuk BScPharm

In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the evidence addresses the issue of primary versus secondary prevention. We then give you all the numbers and the context you need to allow you to…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #625: Blood Pressure Measurement Technique: Meaningful mistakes or minor details?

In episode 625, Mike K and James invite Danielle Perry and Tony Nickonchuk to the podcast to talk about the evidence around blood pressure measurement techniques. You might be surprised…
Listen 0.5 credits available

BS Medicine Episode #624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?

In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the…
Listen 0.5 credits available

FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale

Le groupe d'intérêt des membres sur la santé des patients 2SLGBTQ+ a collaboré avec projet NUANCES, centre de soins en diversité sexuelle et de genre. Dre Judith Lajeunesse et Charlotte…
Listen 0.5 credits available

Presenter(s):

James McCormack Pharm D Mike Kolber MD MSc CCFP Tony Nickonchuk BScPharm

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • James McCormack Pharm D
  • Mike Kolber MD MSc CCFP
  • Tony Nickonchuk BScPharm

Speakers do not have any conflicts of interest to declare.